Dr Reddy's Laboratories has reportedly initiated a voluntary recall of anti-seizure drug Divalproex extended release tablets from the US market owing to cGMP deviations noticed in certain batches of the product.
According to the US Food and Drug Administration (USFDA) report, the company has started recalling of Divalproex 100-count and 500-count bottles, totaling 33,958 bottles on April 11, 2019 after finding out that the product was exposed to humidity levels above 50 percent during packaging.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
